Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$545,058
+$134,105 QoQ
Shares Held
13,933
-8.3% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Derivatives in RIGL
reported options exposure · as of Dec 31, 2021CallValue
$46,640
CallShares
1,760
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. RIGL ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in RIGL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $545,058 | 13,933 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $410,953 | 15,198 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,227,625 | 75,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,446,671 | 51,065 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,120,165 | 59,806 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $525,505 | 29,211 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $527,071 | 31,336 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $442,442 | 27,345 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $86,909 | 10,573 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $222,840 | 150,568 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $357,429 | 246,503 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $44,979 | 41,648 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $58,689 | 45,496 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $130,294 | 98,708 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $69,504 | 46,336 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $8,634 | 7,317 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $9,786 | 8,661 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $145,098 | 48,528 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $549,570 | 207,385 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $46,640 | 17,600 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $1,296,795 | 357,244 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,026,201 | 236,452 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,449,816 | 423,923 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $538,604 | 153,887 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $442,317 | 184,299 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $455,594 | 248,959 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $325,188 | 208,455 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||